Introduction to the treatment of endometrial hyperplasia by curettage and dilation

Endometrial hyperplasia is a problem that many women face nowadays, and this situation will naturally affect women's reproductive health. Therefore, we need to understand effective treatment and coping methods to reduce the harm caused by this disease as much as possible. Let's learn about the treatment of endometrial hyperplasia and see if curettage treatment is necessary.

First of all, a clear diagnosis should be made and the cause should be identified. If accompanied by polycystic ovary, functional ovarian tumors, or other endocrine dysfunction, targeted treatment should be given. At the same time, symptomatic treatment should be started immediately for those diagnosed with atypical endometrial hyperplasia, using medication or surgical treatment. The choice of plan should be determined based on the patient's age, fertility requirements, and physical health condition. For those under 40 years old, their tendency to cancer is low and drug treatment can be considered first. Young people who hope to have children should try drug treatment first, because after drug treatment, about 30% of patients may still become pregnant and give birth to a full-term baby. For women before and after menopause, the potential for cancer is higher than that of younger people, so hysterectomy is often performed directly.

1. The principle of drug treatment is

Standardized medication, long-term examinations, regular testing, and timely assisted pregnancy. Types of medication: ① The ovulation-inducing drug clomiphene is taken once a day on the 5th to 9th day of the cycle. If necessary, the medication period can be extended by 2 to 3 days. ② Progestin drugs: They vary according to the degree of endometrial atypicality. Mild atypical hyperplasia can be treated with intramuscular injection of progesterone, starting on the 18th or 20th day of the cycle, and taken for 5-7 days. Patients with moderate and severe atypical hyperplasia should use medroxyprogesterone continuously for a course of 3 months. After each course of treatment, a curettage or removal of endometrial tissue should be performed for histological examination. Depending on the response to the drug, the patient can choose to stop treatment or increase or decrease the dosage of the drug as appropriate. An intrauterine ring can also be placed.

2. Surgery

Curettage and aspiration is not only an important diagnostic method, but also one of the treatment methods. Because local lesions can also be removed through curettage. Patients with atypical endometrial hyperplasia who are over 40 years old and have no fertility requirements can undergo hysterectomy once diagnosed. However, for patients with hypertension, diabetes, obesity or advanced age who have poor tolerance to surgery, drug treatment may be considered under close follow-up monitoring. Young patients who have not responded to drug treatment, whose endometrial hyperplasia continues or worsens or is suspected of having developed cancer, whose vaginal bleeding cannot be controlled by curettage and drug treatment, and whose condition recurs after delivery, may all consider surgical removal of the hysterectomy.

In fact, through the above content, we will find that curettage is a treatment method for endometrial hyperplasia. But in fact, in life, the treatment of endometrial hyperplasia is not only curettage. It must be treated according to the patient's condition, so every patient friend should not blindly take medicine on their own.